Clinical trial Recruiting at 10 sites Interventional Ages 22 and up Women only

Using an antibacterial matrix device for breast reconstruction

Official title: Absorbable Antibacterial Soft Tissue Support in Breast Reconstruction With Infection Outcomes Assessment (ARIA)

Run by Melodi Health, Inc. · NCT06027996 · Data updated 2026-11-12

This study is testing whether an antibacterial device can help improve recovery and reduce complications for patients getting breast reconstruction after a mastectomy.

Quick facts

Study typeInterventional
Ages22 Years and up
SexWomen only
Enrollment702 (estimated)
SponsorMelodi Health, Inc.
Industry-sponsored
Locations10 sites (Palo Alto, California and 9 other locations)
StatusRecruiting
StartedAugust 9, 2024
Main results expectedDecember 2027
Study endsJune 2028
Registry record updatedDecember 8, 2025
Trial IDNCT06027996 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are females aged 22 or older scheduled for unilateral or bilateral mastectomy with immediate reconstruction.

Probably not a fit

Patients with a history of neoadjuvant radiotherapy or those with active infections may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the safety and effectiveness of an absorbable antibacterial matrix device in patients undergoing two-stage prepectoral alloplastic breast reconstruction following mastectomy. It is a prospective, multicenter, randomized, controlled trial designed to compare outcomes between those receiving the matrix device and those who do not. The study aims to assess how this device may improve surgical outcomes and reduce complications in breast reconstruction procedures.

Why it matters

Potential benefit: If successful, this approach could enhance recovery and reduce infection rates in patients undergoing breast reconstruction.

How similar studies have gone: Other studies have shown promising results with similar antibacterial approaches in surgical settings, suggesting potential for success in this trial.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Female.
* Age 22 or older at the time of enrollment.
* Is scheduled to undergo unilateral or bilateral mastectomy (including prophylactic) with immediate two-stage post-mastectomy alloplastic prepectoral breast reconstruction.
* Is able to and willing to comply with the study requirements and providing informed consent.

Exclusion Criteria:

* Has prior history of neoadjuvant radiotherapy.
* Has had prior history of failed tissue expansion or breast implantation at the intended reconstruction site.
* Has an active abscess or infection requiring antibiotics anywhere in their body within 30 days.
* Has a Body Mass Index (BMI) \< 14 or \> 40.
* Is pregnant or is nursing; or plans to become pregnant during the course of the study.
* Has any connective tissue/autoimmune disorder or rheumatoid disease.
* Has known allergies to study device materials.
* Is participating in another interventional research study that may interfere with study endpoints.
* Has limited life expectancy or co-morbid conditions, social/psychological problems, or cognitive impairments that precludes participation.
* Has a medical condition or is taking medications that would result in elevated risk and/or affect the validity of the study.
* Intraoperative assessment demonstrates unfavorable conditions (i.e., poor mastectomy skin flap thickness or viability) for immediate, two-stage post-mastectomy alloplastic prepectoral reconstruction in any breast.

Where it's running

  • Stanford University
    Palo Alto, California, United States
    Recruiting
  • University of Michigan Health
    Ann Arbor, Michigan, United States
    Recruiting
  • Mayo Clinic
    Rochester, Minnesota, United States
    Recruiting
  • Northwell Health
    Staten Island, New York, United States
    Recruiting
  • The Ohio State University
    Columbus, Ohio, United States
    Recruiting
  • Upmc
    Pittsburgh, Pennsylvania, United States
    Recruiting
Show 4 more locations
  • Medical University of South Carolina
    Charleston, South Carolina, United States
    Recruiting
  • Monument Health
    Rapid City, South Dakota, United States
    Recruiting
  • MD Anderson Cancer Center
    Houston, Texas, United States
    Recruiting
  • University of Utah
    Salt Lake City, Utah, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.